Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 27;11(13):3699.
doi: 10.3390/jcm11133699.

Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients

Affiliations

Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients

Marijana Mikacic et al. J Clin Med. .

Abstract

Although the number of cases and mortality of COVID-19 are seemingly declining, clinicians endeavor to establish indicators and predictors of such responses in order to optimize treatment regimens for future outbreaks of SARS-CoV-2 or similar viruses. Considering the importance of aberrant immune response in severe COVID-19, in the present study, we aimed to explore the dynamic of serum TNF-like weak inducer of apoptosis (TWEAK) levels in critically-ill COVID-19 patients and establish whether these levels may predict in-hospital mortality and if TWEAK is associated with impairment of testosterone levels observed in this population. The present single-center cohort study involved 66 men between the ages of 18 and 65 who were suffering from a severe type of COVID-19. Serum TWEAK was rising during the first week after admission to intensive care unit (ICU), whereas decline to baseline values was observed in the second week post-ICU admission (p = 0.032) but not in patients who died in hospital. Receiver-operator characteristics analysis demonstrated that serum TWEAK at admission to ICU is a significant predictor of in-hospital mortality (AUC = 0.689, p = 0.019). Finally, a negative correlation was found between serum TWEAK at admission and testosterone levels (r = -0.310, p = 0.036). In summary, serum TWEAK predicts in-hospital mortality in severe COVID-19. In addition, inflammatory pathways including TWEAK seem to be implicated in pathophysiology of reproductive hormone axis disturbance in severe form of COVID-19.

Keywords: COVID-19; TWEAK; acute respiratory distress syndrome; biomarker; inflammation; testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of serum TWEAK with regards to in-hospital mortality. Data are presented as median and 75th percentile * Mann–Whitney U test.
Figure 2
Figure 2
Spearman rank correlation analysis between Brixia score and serum TWEAK levels. The red line represents a correlation line, the dotted green lines represent 95% confidence interval, and blue triangles represent values from respective patients.
Figure 3
Figure 3
Receiver-operator characteristics (ROC) analysis of serum TWEAK at admission for in-hospital mortality. Abbreviations: AUC, area under the curve.

References

    1. Pak A., Adegboye O.A., Adekunle A.I., Rahman K.M., McBryde E.S., Eisen D.P. Economic Consequences of the COVID-19 Outbreak: The Need for Epidemic Preparedness. Front. Public Health. 2020;8:241. doi: 10.3389/fpubh.2020.00241. - DOI - PMC - PubMed
    1. Singh S.P., Pritam M., Pandey B., Yadav T.P. Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review. J. Med. Virol. 2020;93:275–299. doi: 10.1002/jmv.26254. - DOI - PMC - PubMed
    1. Malik P., Patel U., Mehta D., Patel N., Kelkar R., Akrmah M., Gabrilove J.L., Sacks H. Biomarkers and outcomes of COVID-19 hospitalisations: Systematic review and meta-analysis. BMJ Evid. Based Med. 2020;26:107–108. doi: 10.1136/bmjebm-2020-111536. - DOI - PMC - PubMed
    1. Chauhan A.J., Wiffen L.J., Brown T.P. COVID-19: A collision of complement, coagulation and inflammatory pathways. J. Thromb. Haemost. 2020;18:2110–2117. doi: 10.1111/jth.14981. - DOI - PMC - PubMed
    1. Dorward D.A., Russell C.D., Um I.H., Elshani M., Armstrong S.D., Penrice-Randal R., Millar T., Lerpiniere C.E.B., Tagliavini G., Hartley C.S., et al. Tissue-Specific Immunopathology in Fatal COVID-19. Am. J. Respir. Crit. Care Med. 2021;203:192–201. doi: 10.1164/rccm.202008-3265OC. - DOI - PMC - PubMed

LinkOut - more resources